Table 1.
Cardiac laboratory markers of COVID-19 patients.
| Patients | LDH | CK | CK-MB | cTnI | Mb | α-HBDH | AST | NT-proBNP |
|---|---|---|---|---|---|---|---|---|
| n = 41 [29] | 29/40 (73) ICU 12/13 (92) No-ICU 17/27 (63) |
13/40 (33) ICU 6/13 (46) No-ICU 7/27 (26) |
— | 5/41 (12) ICU 4/13 (31) No-ICU 1/28 (4) |
— | — | 15/41 (37) ICU 8/13 (62) No-ICU 7/28 (25) |
— |
| n = 99 [45] | 75/99 (76) | 13/99 (13) | — | — | 15/99 (15) | — | 35/99 (35) | — |
| n = 188 [2] | 129/188 (68.6) | 21/188 (11.2) | 19/188 (10.1) | 21/188 (11.2) | — | 143/188 (76.1) | — | — |
| n = 267 [31] | 57/267 (21.3) 39/217 (18.0) Nonsevere 39/50 (18.0) Severe |
50/267 (18.7) 32/217 (14.7) Nonsevere 18/50 (36.0) Severe |
— | 3/76 (3.9) 0/55 (0) Nonsevere 3/21 (14.3) Severe |
8/76 (10.5) 1/55 (1.8) Nonsevere 7/21 (33.3) Severe |
— | — | — |
| n = 140 [46] | — | 4/60 (6.7) 1/35 (2.8) Nonsevere 3/25 (12.0) Severe |
— | — | — | — | — | — |
| n = 1099 [47] | 277/675 (41.0) | 90/657 (13.7) | — | — | — | — | 168/757 (22.2) | — |
| n = 12 [16] | 11/12 (91.7) | 1/6 (16.7) | 1/12 (8.3) | 1/12 (8.3) | 2/12 (16.7) | — | 2/12 (16.7) | — |
| n = 62 [48] | 17/62 (27.4) | 5/62 (8.1) | — | — | — | — | 10/62 (16.1) | — |
| n = 101 [49] | — | — | 32/101 (31.68) Admission to ICU 56/101 (55.45) 48 h to death |
51/101 (50.50) Admission to ICU 73/101 (72.28) 48 h to death |
— | — | — | 37/101 (36.63) Admission to ICU 41/101 (40.59) 48 h to death |
| n = 19 [50] | 6/19 (31.58) | 1/18 (5.56) | — | — | — | 6/8 (75.0) | 5/18 (27.78) | — |
| n = 148 [51] | 52/148 (35.1) | — | — | — | — | — | 32/148 (21.6) | — |
| n = 29 [52] | 20/29 (69) | — | — | — | — | — | — | — |
| n = 2 [53] | 1/2 (50) | — | — | — | — | — | — | — |
| n = 82 [30] | 68/73 (93.2) | 25/72 (34.7) | 21/70 (30.0) | 52/60 (86.7) | 42/70 (60.0) | — | 44/72 (61.1) | — |
| n = 46 [54] | 9/46 (19.6) | 2/46 (4.4) | — | — | — | — | 3/46 (6.5) | — |
| n = 102 [55] | 37/102 (36.3) | 19/102 (18.6) | 11/102 (10.8) | — | 4/59 (6.8) | 37/102 (36.3) | 26/102 (25.5) | — |
| n = 200 [56] | — | — | — | 137/200 (68.5) 112/166 (67.5) Alive cases 25/34 (73.5) Dead cases |
— | — | — | — |
| n = 34 [57] | 10/34 (29.4) | — | — | — | — | — | — | — |
| n = 9 [58] | — | — | — | — | — | — | 3/9 (33.3) | — |
Laboratory data is reported as percent of patients with abnormalities defined according to the local reference ranges. No./total No. (%); ICU: intensive care unit; LDH: lactose dehydrogenase; CK: creatine kinase; CK-MB: creatinine kinase-muscle/brain activity; cTnI: cardiac troponin I; Mb: myoglobin; α-HBDH: alpha-hydroxybutyrate dehydrogenase; AST: aspartate aminotransferase; NT-proBNP: N-terminal of the prohormone brain natriuretic peptide.